Patent Litigation

We have handled hundreds of proceedings before PTAB for a diverse group of clients—both on the patent owner and the petitioner sides. Our track record speaks volumes, with numerous high-stakes cases successfully navigated through the PTAB process, resulting in favorable decisions and substantial victories for clients. Because these proceedings are a unique combination of patent litigation and patent prosecution, they require strategic-minded attorneys with both litigation and technical skills. Leveraging a diverse team of seasoned litigators and technical attorneys, we excel in crafting persuasive arguments, developing innovative strategies, and providing insightful guidance to clients across various industries before the PTAB. We have successfully employed the use of these proceedings as part of a complete litigation strategy to obtain favorable results for our clients. 

We have over 80 years of collective ITC experience and have litigated more than 100 patent infringement cases before the ITC. Our team includes attorneys who have first-chaired successful ITC trials; a former ITC Senior Investigative Attorney; former U.S. Patent Examiners; and more than 50 attorneys with technical degrees in electrical, mechanical, chemical, and biomedical engineering, and other sciences. We have the education and industry experience to understand the complex technology immediately, a working knowledge of the specialized administrative procedural law, and the substantive experience to formulate and execute the strategies necessary to succeed at the ITC.

We have decades of experience handling patent appeals before the Federal Circuit. In the last five years, we have represented clients in 130 Federal Circuit appeals. Our team combines extensive patent litigation experience with top-tier appellate advocacy to help clients achieve the best possible outcomes in the Circuit. 

Learn More

We are litigating at the cutting edge of biotech patent litigation. We possess a unique blend of technical proficiency, legal acumen, and industry knowledge, which enables us to represent biologic companies and biosimilar manufacturers effectively in high-stakes disputes. Leveraging our extensive experience in patent litigation and Hatch-Waxman matters, we craft innovative strategies tailored to the specific nuances of each case. From winning one of the largest biotech patent verdicts to representing one of the first companies to file an application pursuant to the Biologics Price Competition and Innovation Act (BPCIA), we are making history in the biotech sector.

We are unquestionably among the premier law firms representing generic pharmaceutical companies in Abbreviated New Drug Application (ANDA) patent litigation. Since 2018, we have appeared in more than 100 ANDA cases—more than any other national law firm. Through our proven track record and unwavering dedication to the interests of clients, our ANDA litigation practice sets the industry standard. We represent clients in litigation for best-selling drugs such as the blockbuster pain drug OxyContin®; dry-eye treatment drug Restasis®; psoriasis drug Otezla®; dermatology drug Oracea®; and diabetes treatments Jardiance®, Glyxambi®, Synjardy®, and Synjardy XR®.

Cable, internet, and telecommunications patent litigation is an area in which we are well versed. From major internet service providers (ISPs) and software companies to online and mobile platforms, video game publishers, and app developers, we regularly defend ISPs in high-stakes patent litigation. We know and have litigated the protocols, systems, and networks that implement all levels of broadcasting and communications, and we routinely handle cases involving the systems issues that define internetworking and telecommunications from a variety of perspectives. We are experienced in litigating the architecture, software, and features of the industry’s handsets—as well as the chips inside of them—and the software that runs them. We know as much as there is to know about these technologies and how to litigate them.

Our technical attorneys have extensive semiconductor experience, including a combination of electrical engineering (EE) degrees, industry and design experience, and legal practice experience in the EE and/or semiconductor space. We represent seven of the top 20 global semiconductor companies in patent matters. We have experience litigating semiconductor fabrication techniques, including photolithography, etching (plasma/chemical and isotropic/anisotropic), CMP, and deposition (e.g., PVD, CVD, ECD); semiconductor design, including design of high-speed chipsets, layout, simulation/modeling, and testing (wafer and device); modern chip architectures and technologies, including system-on-chip, RISC, and FPG; processing, including fabrication toolsets and processes; yield and contamination issues; semiconductor evaluation and analysis, including working with Semiconductor Insights and other outfits and interpreting SEMs or TEMs; relevant standards; and cross-border legal issues, including anti-suit injunctions.